These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6659572)

  • 21. [Treatment of cerebrovascular insufficiency. A trial of orphol in 8940 patients by 800 medical practitioners (author's transl)].
    Kukwa L
    MMW Munch Med Wochenschr; 1981 Feb; 123(8):310-4. PubMed ID: 6783887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids.
    Jansen W; Bruckner GW; Jansen P
    J Int Med Res; 1985; 13(1):48-53. PubMed ID: 3884411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dose-response study with dihydroergotoxine mesylate in cerebrovascular disturbances.
    Yoshikawa M; Hirai S; Aizawa T; Kuroiwa Y; Goto F; Sofue I; Toyokura Y; Yamamura H; Iwasaki Y
    J Am Geriatr Soc; 1983 Jan; 31(1):1-7. PubMed ID: 6336765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of cerebrovascular insufficiency. A psychometric double-blind trial with a slow-release form of xantinol nicotinate (author's transl)].
    Brückner GW; Jansen W
    MMW Munch Med Wochenschr; 1979 Jun; 121(25):861-4. PubMed ID: 111104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of dihydro-ergotoxine-methanesulphonate in senile cerebral circulatory disorders and hypertension.
    Kovách G
    Ther Hung; 1986; 34(1):21-5. PubMed ID: 3447297
    [No Abstract]   [Full Text] [Related]  

  • 26. Hydergine: a review of 26 clinical studies.
    McDonald RJ
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):407-22. PubMed ID: 538085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Controlled clinical trial of dihydroergocristine in neuropsychiatric disorders in cerebrovascular insufficiency].
    Muchnik S
    Boll Chim Farm; 1982 May; 121(5):33S-46S. PubMed ID: 6814466
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of cerebral wasting diseases with Card-Hydergin].
    Liebhart M
    Med Welt; 1976 Nov; 76(48):2341-6. PubMed ID: 794620
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of Redergam (Latergal) in vascular diseases.
    Kovács E
    Ther Hung; 1986; 34(4):238-42. PubMed ID: 3449979
    [No Abstract]   [Full Text] [Related]  

  • 30. DH Ergotoxin (Spofa) sublingual tablets in the treatment of cerebrovascular insufficiency in involution: clinical and experimental psychologic study.
    Misurec J; Morávek Z; Náhunek K; Cesková E; Sláma B; Svestka J
    Act Nerv Super (Praha); 1978 Dec; 20(4):266-7. PubMed ID: 367038
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of cerebrovascular insufficiency. A double blind trial of Cetal retard against cinnarizine (author's transl)].
    Bartels H
    MMW Munch Med Wochenschr; 1977 Oct; 119(43):1407-10. PubMed ID: 412079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)].
    Mikus P
    Arzneimittelforschung; 1978; 28(11):2165-8. PubMed ID: 582924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
    van Loveren-Huyben CM; Engelaar HF; Hermans MB; van der Bom JA; Leering C; Munnichs JM
    J Am Geriatr Soc; 1984 Aug; 32(8):584-8. PubMed ID: 6379022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of acetyl-L-carnitine on reaction times in patients with cerebrovascular insufficiency.
    Arrigo A; Casale R; Buonocore M; Ciano C
    Int J Clin Pharmacol Res; 1990; 10(1-2):133-7. PubMed ID: 2387660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Double-blind study of the therapeutic activity of cerebroxine in the treatment of chronic cerebral circulatory insufficiency].
    Holemans P
    Brux Med; 1979 May; 59(5):279-85. PubMed ID: 380784
    [No Abstract]   [Full Text] [Related]  

  • 36. [Taurine in the treatment of diffuse cerebral arteriopathies. Clinical and electroencephalographic observations and psychological tests].
    Montanini R; Gasco P
    Clin Ter; 1974 Dec; 71(5):427-36. PubMed ID: 4448048
    [No Abstract]   [Full Text] [Related]  

  • 37. Hydergine in senile mental impairment.
    Loew DM; Weil C
    Gerontology; 1982; 28(1):54-74. PubMed ID: 7037548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Methodology of a controlled trial of dihydroergotoxine in acquired intellectual impairment in the adult].
    Dartigues JF; Père JJ
    Presse Med; 1983 Dec; 12(48):3173-5. PubMed ID: 6228936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sinus bradycardia following treatment with hydergine for cerebrovascular insufficiency.
    Dcayley AC; Macpherson A; Wedgwood J
    Br Med J; 1975 Nov; 4(5993):384-5. PubMed ID: 811310
    [No Abstract]   [Full Text] [Related]  

  • 40. [Electroencephalography and psychometric measurements during the treatment of cerebral insufficiency with nicergoline and dihydroergotamine mesylate].
    Kugler JE; Meurer-Krüll BC
    Arzneimittelforschung; 1985; 35(12):1865-70. PubMed ID: 3913425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.